Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
D000818:Animals; D000941:Antigens; D000951:Antigens, Neoplasm; D002850:Chromatography, Gel; D003016:Clostridium perfringens / Q000201:enzymology; D003851:Deoxyribonucleases / Q000494:pharmacology; D005260:Female; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D007939:Leukemia L1210 / Q000276:immunology* / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D003012:Microbial Collagenase / Q000494:pharmacology; D009368:Neoplasm Transplantation; D009438:Neuraminic Acids / Q000378:metabolism; D009439:Neuraminidase / Q000494:pharmacology*; D009975:Orthomyxoviridae / Q000201:enzymology; D012260:Ribonucleases / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014734:Vibrio cholerae / Q000201:enzymology
D000941:Antigens; D000951:Antigens, Neoplasm; D009438:Neuraminic Acids; D003851:Deoxyribonucleases; D012260:Ribonucleases; D009439:Neuraminidase; D006821:Hyaluronoglucosaminidase; D014357:Trypsin; D003012:Microbial Collagenase